Idexx Laboratories (IDXX) Net Cash Flow (QoQ) (2009 - 2026)
Powered by 
Analysis
Idexx Laboratories (IDXX) Net Cash Flow (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -116.56% |
| Mar 31, 2026 | 175.78% |
| Dec 31, 2025 | -163.57% |
| Sep 30, 2025 | 426.72% |
| Jun 30, 2025 | 88.92% |
| Mar 31, 2025 | -1,050.65% |
| Dec 31, 2024 | 89.21% |
| Sep 30, 2024 | -2,001.84% |
| Jun 30, 2024 | 109.85% |
| Mar 31, 2024 | -144.60% |
| Dec 31, 2023 | -41.67% |
| Sep 30, 2023 | 824.11% |
| Jun 30, 2023 | 1,398.27% |
| Mar 31, 2023 | -122.46% |
| Dec 31, 2022 | 182.86% |
| Sep 30, 2022 | 88.88% |
| Jun 30, 2022 | -236.63% |
| Mar 31, 2022 | 57,003.85% |
| Dec 31, 2021 | 100.12% |
| Sep 30, 2021 | 30.37% |